Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Hot flashes are hypothalamic

July 18, 2018

RegenxBio initiates first-in-human trial of RGX-111 for treatment of MPS I

July 17, 2018

Longitudinal study confirms fat, disputes sugar as obesity cause in mice

July 17, 2018

Animal model of HAAF provides insight on pathological process of the disease

July 17, 2018

Novel mouse model of miR-7-induced pancreatic beta-cell dedifferentiation

July 17, 2018

Cognitive, somatic stabilization by treatment with IgG-IDUA fusion protein in children with MPS I

July 17, 2018

RegenxBio begins first-in-human study with RGX-121 gene therapy for Hunter's syndrome

July 16, 2018

Rare, common genetic variants contribute to preterm birth

July 16, 2018

Jiangsu Wanbang Biopharmaceutical cleared to begin clinical trials of SGLT2 inhibitor in China

July 13, 2018

Ono Pharmaceutical initiates phase I study of ONO-5788

July 13, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...
Other news to note for July 22, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Akari, Ashlins, Azurity, Eli Lilly, Engitix, Forge Biologics,...